Atezolizumab in aCoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)

Gelsomino, F; Lamberti, G; Tiseo, M; Rocco, D; Pasello, G; Cecere, FL; Chella, A; Grilli, G; Mandruzzato, M; Tognetto, M; Garassino, MC; Macerelli, M; Novello, S; Roila, F; Colantonio, I; Grossi, F; Fiorentino, M; Ardizzoni, A

Gelsomino, F (corresponding author), St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Via Albertoni 15, I-40138 Bologna, Italy.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020; 12 ():

Abstract

Background: Although immunotherapy with immune-checkpoint inhibitors (ICIs) has profoundly changed the therapeutic scenario in the treatment of advanc......

Full Text Link